MAPT and Parkinson disease: Many others have shown no association between cognitive test performance, cognitive diagnosis, or rate of cognitive decline and the H1 haplotype15,16,48–51 or rs356219,15,52 and our study provides additional evidence that the MAPT H1 haplotype and SNCA rs356219 do not play a key role in cognitive decline in PD.